Experiment 909591

Details

PropertyValue
Pharmacology
Administration routeIV INFUSION
OrganismEmpty organism
CitationANON:. (1990). TAXOL.. 15(1)
Amount utilized
Compound isolated
Disease47 PATIENTS WITH DRUG REFRACTORY EPITHELIAL OVARIAN CANCER WERE TREATED IN A PHASE II TRIAL. DOSE LIMITING TOXICITY WAS MYELOSUPPRESSION. LEUKOPENIA WAS ASSOCIATED WITH SEPSIS IN 3 CASES, 2 OF WHICH WERE FATAL. OTHER SIDE EFFECTS: MHYALGIAS, ARTHRALGIAS, ALOPECIA, DIARRHEA, NAUSEA, VOMITING, MUCOSITIS AND PERIPHERAL NEUROPATHY. TAXOL WAS ACTIVE IN DRUG REFRACTORY OVARIAN CANCER.
Dose amountVAR
Number3
Qualitative result.
AnimalHUMAN ADULT
Dose expressionDOSE